Pfizer recalls some high blood pressure medications due to cancer risk

Pfizer, the pharmaceutical company behind one of its Covid-19 vaccines, is recalling many of its high blood pressure drugs for containing high levels of nitrosamines, which can increase the risk of cancer.

The company announced a nationwide recall on Monday and said it was recalling six pieces of its Accuretic discs.

It also recalled the licensed generics that Greenstone distributed directly to the patient–one set of quinapril and hydrochlorothiazide tablets, and four amounts of quinapril HCl/hydrochlorothiazide tablets.

Pfizer said nitrosamines are found in food and water, including cured and grilled meats, dairy products, and vegetables. However, his medication was found to contain levels of nitrosamines above the acceptable daily intake level.

“Pfizer places the utmost emphasis on patient safety and product quality at every step of the manufacturing and supply chain process,” the company said in a statement. new version. “Pfizer has notified direct recipients with a letter to arrange the return of any product returned.”

The coupons were distributed nationwide from November 2019 to March 2022. Pfizer said it was not aware of any reports of adverse events related to the recall and that the US Food and Drug Administration was aware of the situation.

“The products have a safety profile built over 20 years of marketing authorization and through a robust clinical program,” the company said.

“Pfizer believes that the benefits/risks of the products remain positive based on currently available data. Although long-term administration of N-nitroso-quinapril may be associated with an increased risk of cancer in humans, there is no immediate risk to patients taking this drug. “.

People who have taken medication should talk to their doctor about other options.

(Visited 1 times, 1 visits today)

Related posts